ARTHUR RONAN: Open Payments
NPI 1346283074 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 44 payments from 16 companies in 2025. Trend: 2023 $1,192 · 2024 $903 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $151 |
| Lilly USA, LLC | 2 | $145 |
| Novo Nordisk Inc | 4 | $93 |
| Eisai Inc. | 3 | $77 |
| Amgen Inc. | 4 | $75 |
| PFIZER INC. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Boston Scientific Corporation | 3 | $59 |
| Exact Sciences Corporation | 3 | $56 |
| Abbott Laboratories | 2 | $49 |
Products named: ZEPBOUND, Leqembi, OTEZLA, VRAYLAR, REXULTI, WATCHMAN FLX, Ozempic, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
